The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ARIAD PHARMACEUTICALS INC | COM | 04033A100 | 11,857,000 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | ||
| BIND THERAPEUTICS INC | COM | 05548N107 | 2,123,500 | 155,000 | SH | SOLE | 155,000 | 0 | 0 | ||
| BIOLINERX LTD | SPONSORED ADR | 09071M106 | 2,067,700 | 713,000 | SH | SOLE | 713,000 | 0 | 0 | ||
| CATALYST PHARM PARTNERS INC | COM | 14888U101 | 2,640,105 | 1,353,900 | SH | SOLE | 1,353,900 | 0 | 0 | ||
| CELATOR PHARMACEUTICALS INC | COM | 15089R102 | 961,000 | 310,000 | SH | SOLE | 310,000 | 0 | 0 | ||
| CELGENE CORP | RIGHT 12/31/2030 | 151020112 | 2,240,000 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| CEMPRA INC | COM | 15130J109 | 4,745,000 | 365,000 | SH | SOLE | 365,000 | 0 | 0 | ||
| CARDIOVASCULAR SYS INC DEL | COM | 141619106 | 4,455,000 | 135,000 | SH | SOLE | 135,000 | 0 | 0 | ||
| FLUIDIGM CORP DEL | COM | 34385P108 | 5,035,000 | 132,500 | SH | SOLE | 132,500 | 0 | 0 | ||
| GERON CORP | COM | 374163103 | 13,200,000 | 2,640,000 | SH | SOLE | 2,640,000 | 0 | 0 | ||
| GENTIUM S P A | SPONSORED ADR | 37250B104 | 29,239,500 | 505,000 | SH | SOLE | 505,000 | 0 | 0 | ||
| INFINITY PHARMACEUTICALS INC | COM | 45665G303 | 1,670,500 | 130,000 | SH | SOLE | 130,000 | 0 | 0 | ||
| INSPIREMD INC | COM NEW | 45779A309 | 2,949,440 | 1,134,400 | SH | SOLE | 1,134,400 | 0 | 0 | ||
| INTERCEPT PHARMACEUTICALS INC | COM | 45845P108 | 3,641,600 | 56,900 | SH | SOLE | 56,900 | 0 | 0 | ||
| KALOBIOS PHARMACEUTICALS INC | COM | 48344T100 | 1,168,500 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
| LIGAND PHARMACEUTICALS INC | COM | 53220K504 | 4,860,000 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
| MEDIVATION INC | COM | 58501N101 | 1,600,000 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
| NOVADAQ TECHNOLOGIES INC | COM | 66987G102 | 2,849,200 | 167,600 | SH | SOLE | 167,600 | 0 | 0 | ||
| NPS PHARMACEUTICALS INC | COM | 62936P103 | 5,945,000 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
| OMEROS CORP | COM | 682143102 | 5,060,000 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
| PHARMACYCLICS INC | COM | 716933106 | 12,960,000 | 120,000 | SH | SOLE | 120,000 | 0 | 0 | ||
| SUNSHINE HEART INC | COM | 86782U106 | 4,123,470 | 425,100 | SH | SOLE | 425,100 | 0 | 0 | ||
| TETRAPHASE PHARMACEUTICALS INC | COM | 88165N105 | 1,995,500 | 153,500 | SH | SOLE | 153,500 | 0 | 0 | ||